As of Feb 24
| +0.34 / +0.47%|
The 17 analysts offering 12-month price forecasts for ResMed Inc have a median target of 66.50, with a high estimate of 78.00 and a low estimate of 50.00. The median estimate represents a -7.59% decrease from the last price of 71.96.
The current consensus among 20 polled investment analysts is to Buy stock in ResMed Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.